Pelosi threat­ens to slide drug pric­ing re­form in­to Biden's bud­get bill, re­jects in­dus­try push­back that in­no­va­tion would suf­fer

Af­ter a re­port re­leased by a key House com­mit­tee showed a pro­ject­ed $1 tril­lion in buy­backs over the next 10 years by Big Phar­ma, Speak­er Nan­cy Pelosi said she wants to at­tach drug pric­ing re­form to the cur­rent bud­get bill, and slammed drug com­pa­nies for sug­gest­ing in­no­va­tion would be harmed as a re­sult.

If passed, the bill would em­pow­er Medicare to ne­go­ti­ate di­rect­ly with drug com­pa­nies to low­er prices, a long­stand­ing goal for De­moc­rats. The House re­port claims the pol­i­cy shift could save tax­pay­ers $456 bil­lion in the next 10 years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER